Date: 20070212
Docket: A-1-07
Citation: 2007 FCA 71
CORAM: LÉTOURNEAU J.A.
SEXTON J.A.
EVANS J.A.
BETWEEN:
APOTEX INC.
Appellant
and
SANOFI-AVENTIS CANADA INC.,
THE MINISTER OF HEALTH and THE ATTORNEY
GENERAL OF CANADA
Respondents
Heard at Toronto,
Ontario, on February 12,
2007.
Judgment delivered from the Bench at Toronto, Ontario, on February 12, 2007.
REASONS FOR JUDGMENT OF THE COURT BY: SEXTON
J.A.
Date: 20070212
Docket: A-1-07
Citation: 2007
FCA 71
CORAM: LÉTOURNEAU
J.A.
SEXTON
J.A.
EVANS
J.A.
BETWEEN:
APOTEX
INC.
Appellant
and
SANOFI-AVENTIS CANADA INC.,
THE MINISTER OF HEALTH and THE ATTORNEY
GENERAL OF CANADA
Respondents
REASONS FOR JUDGMENT OF THE
COURT
(Delivered
from the Bench at Toronto, Ontario, on February 12, 2007)
SEXTON J.A.
[1]
The
facts on which this application is based are clearly set out in the Reasons of
Sharlow J.A. dated January 8, 2007.
[2]
The
issue on the underlying application for judicial review is whether the Minister
of Health (Minister) was correct in issuing a Notice of Compliance ( NOC) to
Apotex for a drug containing the medical ingredient ramipril. We have been
told that the application is scheduled to be heard 3 1/2 weeks from to-day.
[3]
The
issue before us is whether the Motions Judge erred in staying the effect of the
NOC pending the hearing of the judicial review application.
[4]
The
Motions Judge’s decision was that by issuing the NOC, the Minister acted in
disrespect for the Court and as a result, the Court, making use of its inherent
power to control its own process and to properly administer Justice, could
issue a stay.
[5]
The
Motions Judge discussed the tripartite test for granting a stay as
articulated by the Supreme Court of Canada in Manitoba (Attorney General) v.
Metropolitan Stores (MTS) Ltd.,[1981] 1 S.C.R. 110 and held that the
Appellant for the stay, Sanofi-Aventis Canada Inc. had failed to show it would
suffer irreparable harm if a stay were not granted.
[6]
The
issue of whether the Minister was entitled to issue an NOC while a prohibition
application with respect to the same drug was in progress, is a legal issue.
There is certainly an arguable case that the Minister was legally obliged by
the law to issue the NOC if he was of the view that the additional patents
added to the Patent List subsequent to the NOA initially served by Apotex, were
not relevant to the NOA. This would be the situation where the NOC
Regulations could be said not to apply because Apotex could not be said to
be a “second person”. This legal issue is to be decided in the judicial
review.
[7]
If
the Minister was obliged by law to make a decision as to whether or not to
issue the NOC, as is arguably the case, then if the Minister does so, he cannot
be said to be acting in disrespect of the Court. It should be remembered that
the alleged disrespect is not in relation to an Order of the Court but rather
in relation to a legislative stay. If the Minister was wrong, his error would
be one of statutory interpretation, not an act of disrespect to the Court.
[8]
The
effect of the finding of the Motions Judge is that the Minister was acting
improperly in issuing the NOC. He has thus usurped the role of the Judge who
will hear the judicial review application by making the finding that Judge will
have to make.
[9]
We
are of the view therefore that the Motions Judge was not entitled to issue a
stay on the basis only, that the Ministry had improperly issued the NOC in the
situation where the Ministry arguably had the legal obligation to do so.
[10]
We
are of the view that, because the Motions Judge found that Sanofi-Aventis
Canada Inc. had failed to show irreparable harm, there was no other basis on
which a stay could have been granted.
[11]
We
are therefore of the view that the motion Judge erred in issuing the stay.
[12]
The
Appeal will be allowed. The Stay Order will be set aside and the motion of the
Respondent Sanofi-Aventis Canada Inc for a stay of the operation of the NOC
will be dismissed.
[13]
The
Appellant shall have its costs both in this Court and the Court below.
“J.
Edgar Sexton”
FEDERAL COURT OF APPEAL
NAMES OF COUNSEL AND SOLICITORS OF RECORD
DOCKET: A-1-07
(APPEAL FROM
AN ORDER OF THE HONOURABLE MR. JUSTICE VON FINCKENSTEIN, FEDERAL COURT, DATED
DECEMBER 29, 2006, T-2196-06)
STYLE OF CAUSE: APOTEX INC. v. SANOFI-AVENTIS CANADA
INC., THE MINISTER OF HEALTH and THE
ATTORNEY
GENERAL OF CANADA
PLACE OF HEARING: TORONTO, ONTARIO
DATE OF HEARING: FEBRUARY 12, 2007
REASONS FOR JUDGMENT
OF THE COURT BY: (LÉTOURNEAU,
SEXTON, EVANS JJ.A.)
DELIVERED FROM THE
BENCH BY: SEXTON, J.A.
DATED: FEBRUARY 12, 2007
APPEARANCES:
H.B. Radomski
Andrew Bodkin
|
For the
Appellant
|
A. David
Morrow
Gunars A. Gaikis
J. Sheldon Hamilton
Frederick B. Woyiwada
|
For the Respondent, Sanofi-Aventis Canada
Inc.
For the Respondents, Minister of Health
and Attorney General of Canada
|
SOLICITORS
OF RECORD:
GOODMANS LLP
Barristers and Solicitors
Toronto, ON
|
For the
Appellant
|
SMART &
BIGGAR
Barristers and Solicitors
Toronto, ON
John H. Sims,
Q.C.
Deputy Attorney General of Canada
|
For the Respondent, Sanofi-Aventis Canada
Inc.
For the Respondents, Minister of Health
and Attorney General of Canada
|